Redox control of vascular nitric oxide bioavailability.

NO is an important component of vascular homeostasis and abnormal NO bioactivity has been implicated in number of disease states with important public health implications. One clear mechanism of impaired NO bioactivity and vascular disease is excess vascular oxidative stress. There is now a wealth of developing data that manipulation of vascular antioxidant stress is the considerable influence of the biologic activity of endothelium-derived NO. It remains to be seen if this influence can be exploited in a manner that truly alters the course of human disease.

[1]  J. Loscalzo,et al.  Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. , 1998, Journal of the American College of Cardiology.

[3]  D. Harrison,et al.  Atherosclerosis Impairs Endothelium‐Dependent Vascular Relaxation to Acetylcholine and Thrombin in Primates , 1986, Circulation research.

[4]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[5]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[6]  J. Keaney,et al.  Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. , 1998, Circulation research.

[7]  S. Barnes,et al.  Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. , 1994, The Journal of biological chemistry.

[8]  J. Morrow,et al.  Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Kooner,et al.  Hyperhomocysteinemia : An Effect Reversible With Vitamin C Therapy Demonstration of Rapid Onset Vascular Endothelial Dysfunction After , 1999 .

[11]  G. D. Johnston,et al.  The effect of probucol and vitamin E treatment on the oxidation of low‐density lipoprotein and forearm vascular responses in humans , 1994, European journal of clinical investigation.

[12]  P. Wahl,et al.  Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? , 1994, The Journal of clinical investigation.

[13]  B. Frei,et al.  Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. , 1997, Biochimica et biophysica acta.

[14]  D. Stuehr,et al.  Electron Transfer, Oxygen Binding, and Nitric Oxide Feedback Inhibition in Endothelial Nitric-oxide Synthase* , 2000, The Journal of Biological Chemistry.

[15]  L. Ignarro,et al.  Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.

[16]  J. Keaney,et al.  L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. , 1998, The Journal of clinical investigation.

[17]  A. Quyyumi,et al.  Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia. , 1994, Journal of the American College of Cardiology.

[18]  K. Kugiyama,et al.  Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. , 1994, Circulation research.

[19]  J. Morrow,et al.  Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Szewczyk,et al.  Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. , 1991, The Journal of biological chemistry.

[21]  K. Kugiyama,et al.  Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.

[22]  J. Nagy,et al.  Hypercholesterolemia promotes endothelial dysfunction in vitamin E- and selenium-deficient rats. , 1993, Hypertension.

[23]  P. D. Henry,et al.  Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism. , 1980, The Journal of clinical investigation.

[24]  D. Erdogan,et al.  Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. , 1997, Metabolism: clinical and experimental.

[25]  E. Block,et al.  Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. , 1996, Free radical biology & medicine.

[26]  J. Keaney,et al.  Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.

[27]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[29]  D. Harrison,et al.  Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. , 1998, The American journal of the medical sciences.

[30]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[31]  S. Barnes,et al.  Nitration of unsaturated fatty acids by nitric oxide-derived reactive species. , 1999, Methods in enzymology.

[32]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[33]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[34]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. , 1997, Circulation.

[35]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Marshall Fn.  Pharmacology and toxicology of probucol. , 1982 .

[37]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  James B. Mitchell,et al.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Herman,et al.  Effect of Hypercholesterolemia on Vascular Reactivity in the Rabbit: I. Endothelium‐Dependent and Endothelium‐Independent Contractions and Relaxations in Isolated Arteries of Control and Hypercholesterolemic Rabbits , 1986, Circulation research.

[40]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[41]  M. Rudnicki,et al.  A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Mark,et al.  Augmented Responses to Vasoconstrictor Stimuli in Hypercholesterolemic and Atherosclerotic Monkeys , 1984, Circulation research.

[43]  G. Schuler,et al.  Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.

[44]  K. Fukunaga,et al.  Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[45]  S. Padmaja,et al.  The reaction of nitric oxide with organic peroxyl radicals. , 1993, Biochemical and biophysical research communications.

[46]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[47]  J. Keaney,et al.  Antioxidants and atherosclerotic heart disease. , 1997, The New England journal of medicine.

[48]  A. Keech,et al.  Hormone replacement therapy is associated with improved arterial physiology in healthy post‐menopausal women , 1996, Clinical endocrinology.

[49]  S. Snyder,et al.  Generation of superoxide by purified brain nitric oxide synthase. , 1992, The Journal of biological chemistry.

[50]  D. Harrison,et al.  Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.

[51]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J S Beckman,et al.  Pathological implications of nitric oxide, superoxide and peroxynitrite formation. , 1993, Biochemical Society transactions.

[53]  J. Catravas,et al.  Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. , 1992, Circulation research.

[54]  K. Fukunaga,et al.  Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. , 1992, Circulation research.

[55]  G. Buettner.  The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. , 1993, Archives of biochemistry and biophysics.

[56]  H. Kontos,et al.  H2O2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. , 1990, Hypertension.

[57]  J. Zweier,et al.  Superoxide Generation from Endothelial Nitric-oxide Synthase , 1998, The Journal of Biological Chemistry.

[58]  J. Stamler,et al.  NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.

[59]  J. Loscalzo,et al.  Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. , 1995, The Journal of clinical investigation.

[60]  K. Pritchard,et al.  Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. , 1995, Circulation research.

[61]  B. Ames,et al.  Antioxidant defenses and lipid peroxidation in human blood plasma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  T. Andersson,et al.  Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. , 1994, Atherosclerosis.

[63]  V. O’Donnell,et al.  Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol. , 1997, Biochemistry.

[64]  Balaraman Kalyanaraman,et al.  Peroxynitrite modification of low‐density lipoprotein leads to recognition by the macrophage scavenger receptor , 1993, FEBS letters.

[65]  D. Harrison,et al.  Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. , 1991, Circulation research.

[66]  K. Bruckdorfer,et al.  Modulation of vascular tone by low density lipoproteins: effects on L‐arginine transport and nitric oxide synthesis , 1997, Experimental physiology.

[67]  D. Pryor,et al.  Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. , 1995, Circulation.

[68]  W. Koppenol,et al.  Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. , 1997, Chemical research in toxicology.

[69]  L. Foubert,et al.  Safety guidelines for use of nitric oxide , 1992, The Lancet.

[70]  M. Kunitomo,et al.  MECHANISMS OF IMPAIRMENT OF ENDOTHELIUM‐DEPENDENT RELAXATION TO ACETYLCHOLINE IN WATANABE HERITABLE HYPERLIPIDAEMIC RABBIT AORTAS , 1998, Clinical and experimental pharmacology & physiology.

[71]  S. Davidge,et al.  Vascular function in the vitamin E-deprived rat: an interaction between nitric oxide and superoxide anions. , 1998, Hypertension.

[72]  R. Heller,et al.  l-Ascorbic Acid Potentiates Nitric Oxide Synthesis in Endothelial Cells* , 1999, The Journal of Biological Chemistry.

[73]  S. Young,et al.  Probucol inhibits oxidative modification of low density lipoprotein. , 1986, The Journal of clinical investigation.

[74]  S. Abramson,et al.  Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[75]  K. Kugiyama,et al.  Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. , 1998, Journal of the American College of Cardiology.

[76]  K Ito,et al.  Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery disease. , 1998, The American journal of cardiology.

[77]  W. A. Pryor,et al.  Ozonation of methyl oleate in hexane, in a thin film, in SDS micelles, and in distearoylphosphatidylcholine liposomes: yields and properties of the Criegee ozonide. , 1992, Chemical research in toxicology.

[78]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[79]  M. Hori,et al.  Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[80]  R. Dean,et al.  Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[81]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[82]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[83]  C. Kappagoda,et al.  Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. , 1985, Canadian journal of physiology and pharmacology.

[84]  D. Harrison,et al.  Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. , 1995, Circulation.

[85]  A. Quyyumi,et al.  Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.

[86]  R. Cohen,et al.  Preservation of Endothelium‐Dependent Relaxation in Atherosclerotic Rabbit Aorta by Probucol , 1993, Journal of cardiovascular pharmacology.

[87]  M. Wolin,et al.  Inhibition of coronary artery superoxide dismutase attenuates endothelium-dependent and -independent nitrovasodilator relaxation. , 1991, Circulation research.

[88]  G. Schonfeld,et al.  Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. , 1995, The Journal of clinical investigation.

[89]  J. Keaney,et al.  Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. , 1995, The Journal of clinical investigation.

[90]  K. Pritchard,et al.  Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[91]  M. Tarpey,et al.  Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis , 1995, FEBS letters.

[92]  J. Joseph,et al.  Inhibition of low‐density lipoprotein oxidation by nitric oxide Potential role in atherogenesis , 1993, FEBS letters.

[93]  L. Peterson,et al.  Endogenous prostaglandin E2 mediates inhibition of rat thick ascending limb Cl reabsorption in chronic hypercalcemia. , 1993, The Journal of clinical investigation.

[94]  B. Hornig,et al.  Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. , 1997, Circulation.

[95]  J. Loscalzo,et al.  Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. , 1994, The Journal of clinical investigation.

[96]  A. Quyyumi,et al.  Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. , 1995, Hypertension.

[97]  S. Rajagopalan,et al.  Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. , 1997, Circulation.

[98]  K. Kugiyama,et al.  Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. , 1998, Circulation.

[99]  R W Alexander,et al.  Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. , 1994, Circulation research.

[100]  H. Esterbauer,et al.  Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. , 1991, Journal of lipid research.

[101]  J. Crowley,et al.  p-Hydroxyphenylacetaldehyde, the Major Product of l-Tyrosine Oxidation by the Myeloperoxidase-H2O2-Chloride System of Phagocytes, Covalently Modifies ε-Amino Groups of Protein Lysine Residues* , 1997, The Journal of Biological Chemistry.

[102]  K. Kostner,et al.  Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men. , 1998, Journal of the American College of Cardiology.

[103]  J. Liao,et al.  Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase (*) , 1995, The Journal of Biological Chemistry.

[104]  D. Pietraforte,et al.  Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma. , 1997, Free radical biology & medicine.

[105]  L. Ghiadoni,et al.  Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. , 1998, Circulation.

[106]  G. Chisolm,et al.  Intact human ceruloplasmin oxidatively modifies low density lipoprotein. , 1994, The Journal of clinical investigation.

[107]  A. Wendel,et al.  The level and half‐life of glutathione in human plasma , 1980, FEBS letters.

[108]  H. Just,et al.  Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. , 1996, Circulation.

[109]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[110]  F. Azorín,et al.  Formation of Triple-stranded DNA at d(GA·TC)n Sequences Prevents Nucleosome Assembly and Is Hindered by Nucleosomes* , 1996, The Journal of Biological Chemistry.

[111]  J. Simons,et al.  Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. , 1999, Atherosclerosis.

[112]  H. Sies,et al.  Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. , 1991, The Journal of biological chemistry.

[113]  D. Erdogan,et al.  Changes in isoprenaline-induced endothelium-dependent and -independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E. , 1997, General pharmacology.

[114]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[115]  B. Hoffman,et al.  Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. , 1992, The Journal of clinical investigation.

[116]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[117]  D. Wink,et al.  Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. , 1993, Chemical Research in Toxicology.

[118]  C. Taylor,et al.  Tissue glutathione, nutrition, and oxidative stress. , 1993, Canadian journal of physiology and pharmacology.

[119]  G. Levine,et al.  Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. , 1995, The New England journal of medicine.

[120]  L. Ignarro,et al.  Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. , 1988, The Journal of pharmacology and experimental therapeutics.

[121]  J. Stamler,et al.  N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo. , 1997, Hypertension.

[122]  J. Loscalzo,et al.  alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. , 1996, Circulation.

[123]  A. Meister,et al.  Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[124]  S. Barnes,et al.  Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. , 1995, Archives of biochemistry and biophysics.

[125]  E. Anggard,et al.  Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.